STAT+: FDA digital health leader promises generative AI regulatory guidance is coming
Reported by STAT News · all stories from statnews.com
Editorial digest
The leader of the FDA's digital health division has announced that regulatory guidance for generative artificial intelligence tools is forthcoming. This will clarify how the agency plans to oversee this rapidly advancing technology.
Digests are written in our own words from the publisher's headline — we never reproduce article text. Read the original for the full reporting.
Read the full story at STAT News →More like this
Other stories our editors tagged with the same themes.
- Trusted health newsroom10/22/2026
STAT+: FDA finalizes its guidance on apps related to drugs, pharma rejoices
Federal regulators have completed formal guidelines for software applications paired with medications, drawing positive reactions from pharmaceutical manufacturers.
- Trusted health newsroom10/6/2026
STAT+: FDA spells out 2027 AI guidance plans
The FDA has detailed its plans for AI guidelines in 2027.
- Trusted health newsroom10/7/2026
STAT+: Why health AI pilots in Utah may be on a collision course with the FDA
Utah's healthcare artificial intelligence trials may conflict with federal regulatory bodies.
- Trusted health newsroom8/25/2026
STAT+: FDA promises new AI guidance, and what happened at Epic’s UGM
The FDA will issue new AI regulations; Epic's user meeting also had significant updates.
- Trusted health newsroom10/22/2026
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
Virtual clinics are providing off-label GLP-1 therapies for substance use disorders before receiving formal regulatory authorization.
- Trusted health newsroom10/5/2026
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
Utah continues expanding health AI pilot programs for prescriptions and women's health.